Dillan DiNardo

Psychedelics have shown promise in treating various mental health issues, including PTSD and depression, but they’ve often faced notable challenges. Side effects like nausea, cardiovascular risks, and the potential for "bad trips" have raised concerns among both clinicians and patients. As...

A new psychedelics company, part of the 2021 Y Combinator alumni, has officially launched. Mindstate Design Labs is a biotech startup focused on developing new drugs capable of inducing curated states of mind. The company has raised $11.5 million in a seed round and its initial achievement is...